Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: An analysis of the MASTERPLAN cohort

Table 2 Model 1: FGF23 and traditional cardiovascular risk factors

Variable	B	Standard error	Beta	p-value
Male	-0.174	-0.081	-0.89	0.032
Age (year)	-0.003	-0.003	-0.041	0.354
Systolic blood pressure (mmHg)	0.002	0.002	0.043	0.308
Smoking	0.288	0.086	0.136	0.001
BMI	0.021	0.008	0.105	0.011
Diabetes Mellitus	0.154	0.089	0.073	0.084
Total cholesterol (mmol/l)	0.003	0.037	0.004	0.930
History CVD	0.198	0.084	0.100	0.018

Model 1: Relation of lnFGF23 with Framingham risk factors for cardiovascular disease after multivariable analysis. B reflects change in lnFGF23 per unit of the respective variable. For dichotomous variables (sex, smoking, diabetes, and history of CVD) B reflects lnFGF23 change in the presence of the depicted variable. Beta is the standardized B to compare influence on lnFGF23 between variables. BMI: Body mass index; CVD: cardiovascular disease

ISSN: 1471-2369